ctrl K

Price Alert

Kiora Pharmaceuticals Inc... (KPRX)

NASDAQ: KPRX · Real-Time Price · USD

2.93

0.40 (15.81%)

At close: Aug 15, 2025, 3:59 PM

2.90

-1.02%

Pre-market: Aug 18, 2025, 08:13 AM EDT

Kiora Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.79M	2.45M	5.96M	7.85M
Short-Term Investments	23M	n/a	n/a	n/a
Long-Term Investments	4.06K	4.27K	49.26K	45K
Other Long-Term Assets	24.91K	40.77K	82.26K	87.96K
Receivables	871.44K	2.05M	1.37M	529.56K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	2.04M	233.38K	343.07K	n/a
Total Current Assets	29.71M	4.74M	7.68M	8.99M
Property-Plant & Equipment	62.4K	114.95K	172.17K	283.41K
Goodwill & Intangibles	6.69M	8.81M	10.74M	8.7M
Total Long-Term Assets	6.78M	8.97M	11M	9.07M
Total Assets	36.48M	13.71M	18.68M	18.06M
Account Payables	415.59K	206.26K	1.01M	160.62K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	23.36K	47.07K	105.78K	118.85K
Other Current Liabilities	-23.36K	458.34K	740.09K	273.32K
Total Current Liabilities	6.01M	1.63M	3.27M	1.61M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	4.19M	5.13M	3.31M	3.05M
Total Long-Term Liabilities	4.72M	5.97M	4M	3.94M
Total Liabilities	10.72M	7.6M	7.27M	5.55M
Total Debt	57.17K	106.89K	105.78K	209.41K
Common Stock	267.68K	77.08K	17.99K	3.17K
Retained Earnings	-143.38M	-146.98M	-134.46M	-120.88M
Comprehensive Income	-282.16K	-182.8K	-182.74K	-86.43K
Shareholders Equity	25.76M	6.11M	11.41M	14.58M
Total Investments	23M	4.27K	49.26K	45K